The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Role of Circulating MicroRNA-126 (miR-126): A Novel Biomarker for Screening Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus
Abstract
Recent studies suggested an association of endothelial microRNA-126 (miR-126) with type 2 diabetes mellitus (T2DM). In the current study, we examined whether circulating miR-126 is associated with T2DM and pre-diabetic syndrome. The study included 82 subjects with impaired glucose tolerance (IGT), 75 subjects with impaired fasting glucose (IFG), 160 patients with newly diagnosed T2DM, and 138 healthy individuals. Quantitative polymerase chain reaction (qPCR) was used to examine serum miR-126. Serum miR-126 was significantly lower in IGT/IFG subjects and T2DM patients than in healthy controls (p < 0.05). After six months of treatment (diet control and exercise in IGT/IFG subjects, insulin plus diet control and exercise in T2DM patients), serum miR-126 increased significantly (p < 0.05). An analysis based on serum miR-126 in the sample revealed a significantly higher odds ratio (OR) for the subjects with the lowest 1/3 of serum miR-126 for T2DM (OR: 3.500, 95% confidence interval: 1.901–6.445, p < 0.05) than subjects within the highest 1/3 of serum miR-126. Such an association was still apparent after adjusting for other major risk factors. The area under the curve (AUC) for the receiver-operating characteristic (ROC) analysis was 0.792 (95% confidence interval: 0.707–0.877, p < 0.001). These results encourage the use of serum miR-126 as a biomarker for pre-diabetes and diabetes mellitus, as well as therapeutic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MiR-126 expression is significantly decreased in serum and brain after stroke in mice as well as in T2DM patients7, 38, 39.”
From MiR-126 Mediates Brain Endothelial Cell Exosome Treatment–Induced Neurorestorative Effects After Stroke in Type 2 Diabetes Mellitus Mice (2019) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Flagged first, then by citations
Research works printed but not linked: 28
- Ambros, 2001, MicroRNAs: Tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X · DOI
- Bartel, 2009, MicroRNAs: Target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
- Bartel, 2004, MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. USA, 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
- Zubakov, 2010, MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation, Int. J. Leg. Med., 124, 217, 10.1007/s00414-009-0402-3 · DOI
- Park, 2009, Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection, Clin. Cancer, 15, 5473, 10.1158/1078-0432.CCR-09-0736 · DOI
- Jeyaseelan, 2008, MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion, Stroke, 39, 959, 10.1161/STROKEAHA.107.500736 · DOI
- Taylor, 2008, MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer, Gynecol. Oncol., 110, 13, 10.1016/j.ygyno.2008.04.033 · DOI
- Tanaka, 2009, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients, PLoS One, 4, e5532, 10.1371/journal.pone.0005532 · DOI
- Laterza, 2009, Plasma microRNAs as sensitive and specific biomarkers of tissue injury, Clin. Chem., 55, 1977, 10.1373/clinchem.2009.131797 · DOI
- Ji, 2009, Plasma miR-208 as a biomarker of myocardial injury, Clin. Chem., 55, 1944, 10.1373/clinchem.2009.125310 · DOI
- Wang, 2010, Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans, Eur. Heart J., 31, 659, 10.1093/eurheartj/ehq013 · DOI
- Fichtlscherer, 2010, Circulating microRNAs in patients with coronary artery disease, Circ. Res., 107, 677, 10.1161/CIRCRESAHA.109.215566 · DOI
- Tijsen, 2010, MiR423-5p as a circulating biomarker for heart failure, Circ. Res., 106, 1035, 10.1161/CIRCRESAHA.110.218297 · DOI
- Igaz, 2014, Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases, Orv. Hetil., 155, 487, 10.1556/OH.2014.29864 · DOI
- Küçükali, C.I., Kürtüncü, M., Coban, A., Cebi, M., and Tüzün, E. (2014). Epigenetics of multiple sclerosis: An updated review. Neuromol. Med., in press. · DOI
- Nathan, 1993, Long-term complications of diabetes mellitus, N. Engl. J. Med., 328, 1676, 10.1056/NEJM199306103282306 · DOI
- Frankel, 2008, Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: The Framingham offspring study, Circulation, 118, 2533, 10.1161/CIRCULATIONAHA.108.792986 · DOI
- 2010, Endothelial dysfunction, infiammation, and apoptosis in diabetes mellitus, Mediat. Inflamm., 2010, 792393
- Zampetaki, 2010, Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes, Circ. Res., 107, 810, 10.1161/CIRCRESAHA.110.226357 · DOI · Paper page
- Fish, 2008, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell, 15, 272, 10.1016/j.devcel.2008.07.008 · DOI · Paper page
- Wang, 2008, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis, Dev. Cell, 15, 261, 10.1016/j.devcel.2008.07.002 · DOI · Paper page
- Zernecke, 2009, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection, Sci. Signal., 2, ra81, 10.1126/scisignal.2000610 · DOI
- Fichtlscherer, 2011, Circulating micrornas: Biomarkers or mediators of cardiovascular diseases?, Arterioscler. Thromb. Vasc. Biol., 31, 2383, 10.1161/ATVBAHA.111.226696 · DOI
- Asaga, 2011, Hoon1 direct serum assay for microRNA-21 concentrations in early and advanced breast cancer, Clin. Chem., 57, 84, 10.1373/clinchem.2010.151845 · DOI
- Murata, 2013, Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis, PLoS One, 8, e69118, 10.1371/journal.pone.0069118 · DOI
- Gilad, 2008, Serum microRNAs are promising novel biomarkers, PLoS One, 3, e3148, 10.1371/journal.pone.0003148 · DOI
- Wang, 2012, Expression of microRNAs in the urine of patients with bladder cancer, Clin. Genitourin. Cancer, 10, 106, 10.1016/j.clgc.2012.01.001 · DOI
Cited by
Sorted by citations
MicroRNA as Biomarkers and Diagnostics
Wang, J., Chen, J., & Sen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25056 · Cited by 793
MicroRNAs: biomarkers, diagnostics, and therapeutics
Huang, W. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_4 · Cited by 237
Venkat, P., Cui, C., Chopp, M., Zacharek, A., Wang, F., Landschoot-Ward, J., Shen, Y., & Chen, J. (2019) · Stroke · doi:10.1161/strokeaha.119.025371 · Cited by 172
Suresh Babu, S., Thandavarayan, R. A., Joladarashi, D., Jeyabal, P., Krishnamurthy, S., Bhimaraj, A., Youker, K. A., & Krishnamurthy, P. (2016) · Scientific Reports · doi:10.1038/srep36207 · Cited by 119
Metadata
- Authors
- Liu, Y., Gao, G., Yang, C., Zhou, K., Shen, B., Liang, H., & Jiang, X.
- Affiliations
- Department of Clinical Biochemistry Laboratory, the 4th Affiliated Hospital of Harbin Medical University, #37 Yiyuan Street, Nangang District, Harbin 150001, China
- Heilongjiang Province Key Laboratory of Molecular Image, Harbin 150001, China
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-06-12
- Volume
- 15
- Issue
- 6
- Pages
- 10567-10577
- ISSN
- 1422-0067
- PMC
- PMC4100169
- Cited by
- 164
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
